Fresenius SE KGaAXSWX:FRE 71 ROC (Joel Greenblatt) % is 22.28% as of Mar. 2026, which is 2% below its 10-year median of 22.65. GuruFocus rates XSWX:FRE with a GF Score™ of 71/100 and a GF Value™ of CHF33.18 (Fairly Valued). The stock has 5 warning signs investors should review. Among 673 Healthcare Providers & Services companies, Fresenius SE KGaA ranks better than 67.61% on this metric.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Fresenius SE KGaA's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 22.28%.
The historical rank and industry rank for Fresenius SE KGaA's ROC (Joel Greenblatt) % or its related term are showing as below:
XSWX:FRE'
s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 7.15 Med: 22.65 Max: 43.52
Current: 22.95
During the past 13 years, Fresenius SE KGaA's highest ROC (Joel Greenblatt) % was 43.52%. The lowest was 7.15%. And the median was 22.65%.
XSWX:FRE's ROC (Joel Greenblatt) % is ranked better than 67.61% of 673
companies
in the Healthcare Providers & Services industry
Industry Median: 12.46
vs XSWX:FRE: 22.95
Fresenius SE KGaA's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 0.50% per year.
Fresenius SE KGaA (XSWX:FRE) ROC (Joel Greenblatt) % Explanation
The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.
Fresenius SE KGaA ROC (Joel Greenblatt) % Related Terms
Fresenius SE KGaA ROC (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for Fresenius SE KGaA's ROC (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:FRE vs HCA, THC, DVA: ROC (Joel Greenblatt) % Comparison
For the Medical Care Facilities subindustry, Fresenius SE KGaA's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fresenius SE KGaA ROC (Joel Greenblatt) % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Fresenius SE KGaA's ROC (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Fresenius SE KGaA's ROC (Joel Greenblatt) % falls into.
Fresenius SE KGaA ROC (Joel Greenblatt) % Calculation
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:
EBIT stands for Earnings Before Interest and Taxes.
Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.
GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.
Note:
The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROC (Joel Greenblatt) % of 22.28% mean?
Fresenius SE KGaA (XSWX:FRE) has a ROC (Joel Greenblatt) % of 22.28% as of Mar. 2026. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Fresenius SE KGaA and its competitors. This is near median its historical median of 22.65. Over the past decade, Fresenius SE KGaA's ROC (Joel Greenblatt) % has ranged from 7.15 to 43.52. According to the industry distribution chart, Fresenius SE KGaA ranks #218 out of 673 companies in the Healthcare Providers & Services industry, placing it in the top 32.4%.
Is Fresenius SE KGaA's ROC (Joel Greenblatt) % too high?
Fresenius SE KGaA's current ROC (Joel Greenblatt) % of 22.28% is near median its 10-year median of 22.65. Over the past 10 years, this metric has ranged from a low of 7.15 to a high of 43.52. The Healthcare Providers & Services industry median ROC (Joel Greenblatt) % is 12.46. Fresenius SE KGaA's value of 22.28% is 78.8% above this industry median. Based on the distribution chart, Fresenius SE KGaA ranks #218 out of 673 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Fresenius SE KGaA has a GF Score™ of 71/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Fresenius SE KGaA's ROC (Joel Greenblatt) % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Fresenius SE KGaA ranks #218 out of 673 companies for ROC (Joel Greenblatt) %. This puts Fresenius SE KGaA in the upper half of its industry. The industry median ROC (Joel Greenblatt) % is 12.46. Fresenius SE KGaA's value of 22.28% is 78.8% above this benchmark. Historically, Fresenius SE KGaA's own ROC (Joel Greenblatt) % has ranged from 7.15 to 43.52 over the past decade. While the company's 10-year median is 22.65 vs. the industry median of 12.46, Fresenius SE KGaA has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Healthcare Providers & Services company?
The median ROC (Joel Greenblatt) % among Healthcare Providers & Services companies is 12.46, based on 673 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Fresenius SE KGaA's current ROC (Joel Greenblatt) % of 22.28% is 78.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Fresenius SE KGaA and its competitors. For the Healthcare Providers & Services industry, the median ROC (Joel Greenblatt) % is 12.46 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fresenius SE KGaA's current ROC (Joel Greenblatt) % is 22.28%, which is near median its own 10-year median of 22.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fresenius SE KGaA stock overvalued right now?
Based on GuruFocus' analysis, Fresenius SE KGaA (XSWX:FRE) is currently considered Fairly Valued. The stock's GF Value™ is CHF33.18, compared to a current price of CHF36.15 — trading 9% above its estimated fair value. The current ROC (Joel Greenblatt) % is 22.28%, which is near median its 10-year median of 22.65 and 78.8% above the Healthcare Providers & Services industry median of 12.46. Fresenius SE KGaA's overall GF Score™ is 71/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Fresenius SE KGaA (XSWX:FRE), the current ROC (Joel Greenblatt) % is 22.28% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fresenius SE KGaA (XSWX:FRE) Overvalued in 2026?
Based on GuruFocus' analysis, Fresenius SE KGaA stock appears to be overvalued.
The current stock price of CHF36.15 is trading 9% above its estimated GF Value™ of CHF33.18.
GuruFocus considers Fresenius SE KGaA to be Fairly Valued.
Key valuation signals for XSWX:FRE:
ROC (Joel Greenblatt) %: 22.28% (near median its 10-year median of 22.65)
GF Value™: CHF33.18 vs. price of CHF36.15 (9% above fair value)
Industry Position: 78.8% above the Healthcare Providers & Services median (#218 of 673)
No single metric tells the full story. See the XSWX:FRE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fresenius is a healthcare holding company based in Germany. The company owns a minority stake in dialysis service provider and equipment manufacturer Fresenius Medical Care. The Kabi segment manufactures intravenous drugs, nutrition products, infusion and transfusion therapies, and related pumps. The Helios segment operates private hospitals primarily in Germany and Spain.
71GF Score
Get the complete analysis for XSWX:FRE
ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:FRE has been successfully added to your 
